Infecção na modulaçâo da asma ¹

 

J Pinto Mendes

 

 

Resumo

Faz -se uma revisão da influência das infecções no aparecimento e na clínica da asma brônquica. Dá -se o relevo que merece à intervenção virusal, sobretudo ao rinovírus, pela sua influência nas exacerbações, e ao vírus sincicial respiratório, sobre o qual recai a suspeita de poder ser causa determinante no aparecimento da síndroma asmática. Tentam-se esclarecer os mecanismos da resposta imune à agressão virusal em função das debilidades da resposta do asmático e do atópico, sobretudo no período perinatal, salientando -se, ainda, um efeito de potenciação da agressão virusal sobre a resposta atópica. Aborda -se a hipótese higiénica e a sua falta de consistência científica, pelo menos no papel que pretende atribuir a um não demonstrado antagonismo das respostas linfocitárias Th1 e Th2, apontando -se a importância actual da investigação, não das bactérias mas dos produtos bacterianos, como as endotoxinas, na modulação da asma e da atopia, dando -se relevo aos estudos que, a partir deste modelo, demonstram uma influência do ambiente na secreção génica e, consequentemente, no fenótipo.

Invocam -se, nas entrelinhas, vários mecanismos que podem explicar a asma neutrofílica que, para muitos, é um paradoxo perante o consagrado domínio do eosinófilo na inflamação asmática.

Palavras-chave: Asma e infecção, asma e vírus, endotoxinas.

 

 

The role of infection in asthma ¹

Abstract

This paper reviews the impact of infections on the onset and clinical course of bronchial asthma. A just emphasis is given to the role viral infections, particularly rhinovirus infections, play in exacerbations, and that played by respiratory syncytial virus, suspected of triggering the asthmatic syndrome. The mechanisms of the immune response to virus attacks are explained, highlighting the asthmatic and allergic patient’s weakened response, particularly in the perinatal period. Further stressed is a potentiating effect of viral aggression on the allergic response. The hygiene hypothesis and its lack of scientific consistency is detailed, at least as far as the role it seeks to confer on an unproven antagonism of the Th1 and Th2 lymphocyte responses. The current importance of research not into bacteria, but into bacterial products, including endotoxins, on the modulation of asthma and allergy is noted. Studies which, along these lines, show anenvironmental impact on genetic secretion in the phenotype are underlined. Also discussed in passing are several mechanisms which go towards explaining neutrophilic asthma – for many a contradiction, given eosinophilia’s stranglehold on asthmatic inflammation.

Key-words: Asthma and infection, asthma and virus, endotoxins.

 

 

Texto completo disponível apenas em PDF.

Full text only available in PDF format.

 

 

Bibliografia / Bibliography

1. Pelaia A, Vatrella R, Galleli L. e al. Respiratory infections and asthma.Respir Med 2006; 100:775 -84.        [ Links ]

2. Lemanske RF. Viral infections and asthma inception. J Allergy Clin Immunol 2004; 114:1023 -26.

3. Johnston Sl, Pattermore Pk, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9 -11 years old children. BMJ 1995; 1225 -29.

4. Copenhauer Cc, Gern Ge, Li Z, et al. Cytokine response patterns, exposure to viruses and respiratory infection in the first year of life. Am J Respir Crit Care Med 2004;170:175 -80.

5. Nicholson KG, Kent J, Ireland DC. Respiratory virus and exacerbations of asthma in adults. BMJ 1993; 307: 982 -86.

6. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005; 116: 267 -73.

7. Empey DW, Laitinen LA, Jacobs L, et al. Mechanics of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131 -39.

8. Stokes GM, Milner AD, Hodges IGC, Grobbins RC. Lung function abnormalities after acute bronchiolitis. J Pediatr, 1981; 98:871 -74.

9. Haal CB, Halol WJ, Gala CL, et al. Long -term prospective study of children after respiratory syncytial vírus infection. J Pediatr 1984; 105:358 -64.

10. Martin JG, Diddiqui S, Hassan M. Immune responses to viral infections: relevance for asthma. Ped Respir Rev 2006; 75: S125 -S127.

11. Van den Hoogen BG, De Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7:719 -24.

12. Van der Hoek L, Pyrc K, Jerbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10:368 -73.

13. Woo PC, Lau SK, Chu SM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKV1, from patients with pneumonia. J Virol 2005; 79:884 -95.

14. Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 2005; 102: 12891 -6.

15. Pifferi M, Maggi F, Andreoli E, et al. Associations between torquetenovirus load and spirometric indices in children with asthma. J Infect Dis 2005; 192:1141 -8.

16. Freymuth F, Vabret A, Galateau -Salle F, et al. Detection of respiratory syncytial virus, parainfluenza 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridization. Clin Diagn Virol 1997; 8:31 -40.

17. Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev 2004; 5 (Suppl. A): 223 -38.

18. Lemanske RF. Is asthma an infectious disease? Chest 2003; 3: S385 -S390.

19. Weinberger M. Respiratory infections and asthma: current treatment strategies. Drug Discovery Today 2004; 9: 831 -7.

20. Sigurs N, Bjamason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161: 1501 -7.

21. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003; 22:76 -82.

22. Holt PG, Sly PD. Interactions betweem RSV infection, asthma and atopy. Unraveling the complexities. J Exp Med 2005; 196:1271 -5.

23. Husel MMH, De Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105 -10.

24. Hersoug L -G. A reformulation of the hygiene hypothesis: maternal infeccious diseases confer protection against asthma in the infant? Medical Hypothesis 2006; 27: 717 -20.

25. Darkham A, Mok Lee Y, Gelfand EW. Virus –induced airway dysfunction. Pathogenesis and biomechanisms. Ped Infect Dis J 2005; 24(Suppl):S159 -S169.

26. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171:137 -41.

27. Stein R, Sherrill D, Morgan W, et al. Respiratory syncycial virus in early life and risk of wheeze and allergy by age of 13 years. Lancet 1999; 354:541 -45.

28. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory virus in mice. J Clin Invest 1991; 88:1026 -33.

29. Dakhama A, Park JW, Taube C, et al. Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following syncytial virus infection. Am J Physiol Lung Cell Mol Physiol, 2005; 228:L761 -L770.

30. Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory virus by nasally administered siRNA. Nat Med 2005; 11:50 -5.

31. Zhang W, Yang H, Kong X, et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 2005; 11:56 -62.

32. Lemanske RF, Jackson DJ, Gangnon RE, et al. Rhinovirus illness during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol, 2005; 116: 571 -7.

33. Tan WC. Virus in asthma exacerbations. Curr Opin Pulm Med 2005; 11:21 -6.

34. Almström K, Pitkäranta A, Carpen O, et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 2006; 118:591 -6.

35. Holgate ST. Rhinovirus in the pathogenesis of asthma: the bronchial epithelium as a major disease target. J Allergy Clin Immunol 2006; 118:587 -90.

36. Cheung D, Dick EC, Timmers MC, et al. Rhinovirus inhalation causes long -lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995; 152: 1490 -6.

37. Grungerg K, Timmers MC, De Klerk EP, et al. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999; 160:1375 -80.

38. Calvani M, Alessandri C, Bonci E. Fever episodes in early life and the development of atopy in children with asthma. Eur Respir J 2002; 20:391 -6.

39. Korppi M, Piippo -Savolainen E, Korhonen K, Remess S. Respiratory morbidity 20 years after SRV in infancy. Pediatr Pulmonol 2004; 38:155 -60.

40. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994; 94: 2220 -8. 41. Schwarze J, Gelfand EW. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur Respir J 2002; 19:341 -9.

42. Makela MJ, Tripp R, Dakhama A, et al. Prior airway exposure to allergen increases vírus -induced airway hyperresponsiveness. J Allergy Clin Immunol 2003; 112: 861 -9.

43. Schaller M, Hogaboam CM, Wkaks N, Kunkez SL. Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response. J Allergy Clin Immunol 2006; 118:295 -302.

44. Randolph DA, Carruthers CJ, Szabo SJ, et al. Modulation of airway inflammation by passive transfer of allergen -specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162: 23755 -83.

45. Umetsu DT, Abkari V, Dekruyff R. Regulatory T cells control of allergic disease and asthma. J Allergy Clin Immunol 2003; 117:480 -7.

46. Lee RM, White MR, Hartshorn KL. Influenza A viruses upregulate neutrophil Toll -like Receptor 2 expression and function. Scandinavian J Immunol 2006; 63: 81 -9.

47. Pala P, Bjarnason R, Sigurbergsson F, et al. Enhanced IL -4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy. Eur Respir J 2002; 20: 370 -82.

48. Choi EH, Lee HJ, Yoo T, Chanock ST. A common haplotype of interleukin 4 gene is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002; 186:1207 -11.

49. Jackson M, Scott R. Distinct patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific humam Th cell lines following stimulation with RS virus and RS virus proteins. J Med Virol 1996; 49:161 -9.

50. Cochran JR, Khan AM, Elidmir O, et al. Influence of LPS exposure on airway function and allergic responses in developing mice. Pediatr Pulmonol 2002; 34:267 -77.

51. Takeda K, Akira S. Toll -like receptors in innate immunity. Int Immunol 2005; 17:1 -4.

52. Henson CA, Jardine A, Edwards MR, et al. Toll –like Receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005; 79:12 273 -9.

53. Schaub B, Lavener R, Von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2006; 117:967 -77.

54. Wark PAB, Johnston SL, Bucchieri F. et al. Asthmatic bronchial epithelial cells have a deficient innate response to infection with rhinovirus. J Exp Med 2005; 210:937 -47.

55. Van Rijt LS, Van Kessel G, Boogaard I, Lambrecht BN. Respiratory viral infections and asthma pathogenesis: a critical role for dendritic cells? J Clin Virol 2005; 34:161 -9.

56. Mazzoni A, Leifer CA, Mullen GE, et al. Cutting edge: histamine inhibits IFN. alpha release from plasmacytoid dendritic cells. J Immunol 2003; 170:2269 -73.

57. Zuniga EI, Mc Gavern DB, Pruneda -Paz JL ET, et al. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 2004; 5:1227 -34.

58. Kalina WW, Gershwin LJ. Progress in defining the role of RSV in allergy and asthma. Clin Rev Immunol 2004; 11:113 -9.

59. Remes ST, Korppi M. On roots of childhood asthma: the role of respiratory infections. Ann Med 2005; 37:26 -32.

60. Prescott SL, Björkstén G. Probiotic for the prevention of treatment or allergic diseases. J Allergy Clin Immunol 2007; 120:255 -62.

61. Strachan DP. Hay fever, hygiene and household size. BMJ 1989; 299:1259 -60.

62. Peat J, Björksten B. Primary and secondary prevention of allergic asthma. Eur Respir J 1988; 27 (Suppl): 28S -34S.

63. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999; 354 (Suppl 2): 112 -5.

64. Liu AH, Murphy JR. Hygiene hypothesis: fact or fiction? J Allergy Clin Immunol 2003; 111:471 -8.

65. Von Mutius , Illi S, Hirsch T, et al. Frequency of infections in the first years of life and risk of asthma, atopy and airway hyperresponsiveness among schoolage children. Eur Respir J 1999; 14:4 -11.

66. Linehan MF, Fr4ank TL, Hazell ML, et al. Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J Allergy Clin Immunol 2007; 119:1079 -85.

67. Aligne CA, Auinger P, Byrd RS, Weitzman M. Risk factors for pediatric asthma. Contributions of poverty, race and urban residence. Am J Respir Crit Care Med 2000; 162: 873 -7.

68. Yazdanbarkhsh M, Kremsner PG, Van Ree R. Allergy, parasites and hygiene hypothesis. Science 2000; 296: 490 -4.

69. Tantisara KG, Weiss ST. Childhood infections and asthma: at the crossroad of the hygiene and Barker hypothesis. Respir Res 2001; 2:324 -7.

 

 

1 Trabalho apresentado no XXIII Congresso de Pneumologia da SPP – Guarda, Novembro 2007 / Paper presented at the XXIII Congresso de Pneumologia da SPP / PSP Pulmonology Congress, Guarda, November 2007

 

Recebido para publicação/received for publication: 08.05.23

Aceite para publicação/accepted for publication: 08.07.08